...
机译:骨髓恶性肿瘤患者WT1(Wilms肿瘤基因)特异性CD8 + sup> T细胞的T细胞受体BV基因家族的偏爱使用
Departments of Functional Diagnostic Science;
Cancer Immunotherapy;
Respiratory Medicine, Allergy and Rheumatic Diseases;
Cancer Immunotherapy;
Departments of Functional Diagnostic Science;
Departments of Functional Diagnostic Science;
Cancer Immunotherapy;
Cancer Immunotherapy;
Cancer Stem Cell Biology, Osaka University Graduate School of Medicine, Osaka;
Departments of Functional Diagnostic Science;
Respiratory Medicine, Allergy and Rheumatic Diseases;
Cancer Stem Cell Biology, Osaka University Graduate School of Medicine, Osaka;
Departments of Functional Diagnostic Science;
Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan;
Respiratory Medicine, Allergy and Rheumatic Diseases;
Departments of Functional Diagnostic Science;
机译:骨髓恶性肿瘤患者中WT1(Wilms的肿瘤基因)特异性CD8 + T细胞T细胞受体BV基因家族的偏倚用法。
机译:骨髓恶性肿瘤患者WT1(Wilms肿瘤基因)特异性CD8 + SUP> T细胞T细胞受体BV基因家族的偏爱使用
机译:实体瘤患者和健康供体的Wilms肿瘤基因(WT1)特异性CD8 + T细胞T细胞受体β链可变区基因的偏向使用
机译:肿瘤特异性HLA配体靶向可溶性T细胞受体的工程与武装
机译:疱疹病毒特异性CD8 + T细胞上的皮肤归巢分子和趋化因子受体表达
机译:在患有固体肿瘤和健康供体的患者中均匀使用Wilms肿瘤基因(WT1) - 特异性CD8 + T细胞的T细胞受体β-链可变区基因
机译:使用T细胞改性的血液恶性肿瘤造成血液恶性肿瘤疗法表达肿瘤抗原特异性受体